Credit Suisse’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $18.1M | Sell |
257,045
-2,156
| -0.8% | -$154K | 0.02% | 662 |
|
|
2023
Q4 | $20M | Buy |
259,201
+6,972
| +3% | +$459K | 0.02% | 666 |
|
|
2023
Q3 | $17.2M | Sell |
252,229
-5,661
| -2% | -$447K | 0.02% | 682 |
|
|
2023
Q2 | $21.1M | Sell |
257,890
-13,784
| -5% | -$1.11M | 0.02% | 649 |
|
|
2023
Q1 | $20.2M | Buy |
271,674
+9,160
| +3% | +$706K | 0.02% | 662 |
|
|
2022
Q4 | $21.8M | Buy |
262,514
+19,090
| +8% | +$1.52M | 0.02% | 641 |
|
|
2022
Q3 | $17.3M | Buy |
243,424
+2,544
| +1% | +$220K | 0.02% | 708 |
|
|
2022
Q2 | $20.9M | Sell |
240,880
-8,432
| -3% | -$790K | 0.02% | 676 |
|
|
2022
Q1 | $27M | Buy |
249,312
+19,248
| +8% | +$1.99M | 0.02% | 659 |
|
|
2021
Q4 | $29.8M | Sell |
230,064
-2,092
| -0.9% | -$256K | 0.02% | 884 |
|
|
2021
Q3 | $28.1M | Sell |
232,156
-608
| -0.3% | -$74K | 0.02% | 920 |
|
|
2021
Q2 | $26.2M | Buy |
232,764
+49,980
| +27% | +$5.26M | 0.01% | 1025 |
|
|
2021
Q1 | $17.5M | Sell |
182,784
-15,332
| -8% | -$1.4M | 0.01% | 1237 |
|
|
2020
Q4 | $15.7M | Buy |
198,116
+56,776
| +40% | +$4.11M | 0.01% | 1314 |
|
|
2020
Q3 | $8.75M | Sell |
141,340
-107,960
| -43% | -$7.02M | 0.01% | 1457 |
|
|
2020
Q2 | $16.5M | Buy |
249,300
+19,788
| +9% | +$1.19M | 0.01% | 1046 |
|
|
2020
Q1 | $10.9M | Buy |
229,512
+67,904
| +42% | +$3.4M | 0.01% | 1139 |
|
|
2019
Q4 | $8.87M | Buy |
161,608
+59,356
| +58% | +$3.11M | 0.01% | 1489 |
|
|
2019
Q3 | $5M | Sell |
102,252
-31,672
| -24% | -$1.59M | ﹤0.01% | 1762 |
|
|
2019
Q2 | $6.98M | Sell |
133,924
-4,232
| -3% | -$213K | 0.01% | 1534 |
|
|
2019
Q1 | $6.86M | Buy |
138,156
+12,292
| +10% | +$553K | 0.01% | 1477 |
|
|
2018
Q4 | $4.55M | Sell |
125,864
-18,376
| -13% | -$768K | ﹤0.01% | 1640 |
|
|
2018
Q3 | $7.36M | Sell |
144,240
-1,644
| -1% | -$72.8K | 0.01% | 1452 |
|
|
2018
Q2 | $5.4M | Sell |
145,884
-21,152
| -13% | -$808K | 0.01% | 1676 |
|
|
2018
Q1 | $6.31M | Sell |
167,036
-5,200
| -3% | -$184K | 0.01% | 1545 |
|
|
2017
Q4 | $5.58M | Sell |
172,236
-6,804
| -4% | -$216K | 0.01% | 1705 |
|
|
2017
Q3 | $5.41M | Buy |
179,040
+26,140
| +17% | +$776K | 0.01% | 1707 |
|
|
2017
Q2 | $4.49M | Sell |
152,900
-7,912
| -5% | -$216K | ﹤0.01% | 1695 |
|
|
2017
Q1 | $4.08M | Sell |
160,812
-32,256
| -17% | -$833K | ﹤0.01% | 1807 |
|
|
2016
Q4 | $4.96M | Sell |
193,068
-21,852
| -10% | -$574K | ﹤0.01% | 1648 |
|
|
2016
Q3 | $5.88M | Buy |
214,920
+9,544
| +5% | +$262K | 0.01% | 1533 |
|
|
2016
Q2 | $5.79M | Buy |
205,376
+20,996
| +11% | +$540K | 0.01% | 1524 |
|
|
2016
Q1 | $4.36M | Sell |
184,380
-3,136
| -2% | -$69.1K | 0.01% | 1628 |
|
|
2015
Q4 | $4.22M | Buy |
187,516
+17,040
| +10% | +$389K | ﹤0.01% | 1719 |
|
|
2015
Q3 | $3.94M | Sell |
170,476
-263,136
| -61% | -$6.6M | ﹤0.01% | 1739 |
|
|
2015
Q2 | $10.7M | Buy |
433,612
+36,444
| +9% | +$910K | 0.01% | 1208 |
|
|
2015
Q1 | $9.96M | Buy |
397,168
+34,828
| +10% | +$828K | 0.01% | 1197 |
|
|
2014
Q4 | $8.37M | Buy |
362,340
+27,428
| +8% | +$628K | 0.01% | 1395 |
|
|
2014
Q3 | $7.83M | Sell |
334,912
-51,804
| -13% | -$1.21M | 0.01% | 1446 |
|
|
2014
Q2 | $8.95M | Buy |
386,716
+44,312
| +13% | +$979K | 0.01% | 1480 |
|
|
2014
Q1 | $7.31M | Buy |
342,404
+136,844
| +67% | +$3.08M | 0.01% | 1463 |
|
|
2013
Q4 | $4.87M | Sell |
205,560
-5,756
| -3% | -$125K | ﹤0.01% | 1866 |
|
|
2013
Q3 | $4.23M | Sell |
211,316
-22,324
| -10% | -$424K | ﹤0.01% | 1786 |
|
|
2013
Q2 | $4.04M | Buy |
+233,640
| New | +$3.88M | ﹤0.01% | 1752 |
|
Other funds holding TECH
DDC
Credit Suisse's TECH Position: Q1 2024 in Review
Credit Suisse reduced its Bio-Techne (TECH) stake by 0.83% in Q1 2024, selling an estimated $154K and leaving 257,045 shares worth $18.1M. The position accounts for 0.02% of the portfolio, ranked #662.
Credit Suisse first reported a position in TECH in Q2 2013 and has held it in 44 quarters since. The position peaked at $29.8M in Q4 2021. 556 funds tracked by Wall St. Rank hold TECH as of Q1 2024.
- Credit Suisse held 257,045 shares of Bio-Techne worth $18.1M as of Q1 2024.
- Credit Suisse sold 2,156 Bio-Techne shares in Q1 2024, an estimated $154K.
- Bio-Techne made up 0.02% of Credit Suisse's portfolio in Q1 2024, its #662 holding.
- Credit Suisse first reported a position in Bio-Techne in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Bio-Techne position peaked at $29.8M in Q4 2021.
- 556 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.